Joó I, Emöd J
Human Institute for Serobacteriological Production and Research, WHO Collaborating Centre for Reference and Research on Bacterial Vaccines, Budapest, Hungary.
Vaccine. 1988 Jun;6(3):233-7. doi: 10.1016/0264-410x(88)90217-4.
Investigations into the effectiveness of DEAE-dextran as an adjuvant of whole cell cholera vaccines (Vibrio cholerae Inaba and Ogawa serotypes) were conducted using two methods: (a) the active mouse protection test, (b) the determination of antibody production in the sera of immunized mice by measuring the level of vibriocidal antibodies, and by an enzyme-linked immunosorbent assay (ELISA). In all tests, the DEAE-dextran-adjuvanted vaccine showed an antigenicity substantially superior to that achieved without adjuvants.